Metabolic incorporation into sialoglycans (MOE)

Metabolic incorporation into sialoglycans is a laboratory technique used in cell biology and glycobiology research. It involves adding modified sialic acid analogs to cell culture media or administering them to living organisms, where cellular glycosylation machinery processes and incorporates them into cell-surface glycans. This method enables researchers to study sialylation and label glycoconjugates for visualization and analysis. The technique utilizes unnatural sialic acid precursors (e.g., azide- or alkyne-modified sialic acids, protected ManNAc analogs) that are metabolized like natural sialic acids, leading to their incorporation into sialoglycoproteins and glycolipids on the cell surface. This allows for subsequent bioorthogonal chemistry reactions for detection, labeling, and functional studies. Crucially, this is a research tool, not a molecule that drugs directly inhibit or activate, and therefore not a therapeutic target itself. While the underlying biological machinery (sialyltransferases, transport proteins, biosynthetic enzymes) could be therapeutic targets, 'metabolic incorporation' refers to the methodology.

Other names

Metabolic glycoengineeringbioorthogonal metabolic labeling

Metabolic incorporation into sialoglycans works by introducing unnatural sialic acid precursors (such as azide- or alkyne-modified sialic acids, or protected ManNAc analogs) that cells metabolize similarly to natural sialic acids. These modified sugars are then incorporated into sialoglycoproteins and glycolipids on the cell surface, allowing researchers to perform bioorthogonal chemistry reactions for detection, labeling, and functional studies.